Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors and central nervous system (CNS) active compounds. Its structural features enable selective interactions with biological targets, making it valuable in drug discovery programs focused on inflammation, neurological disorders, and oncology. The tert-butoxycarbonyl (Boc) protecting group allows for controlled reactivity during multi-step syntheses, facilitating peptide coupling and heterocycle formation. Its difluorophenyl moiety contributes to enhanced metabolic stability and membrane permeability, which are critical for oral bioavailability in final drug candidates.